NASDAQ · Medical - Devices

BMRA (BMRA) Stock

$1.61 +1.26% NASDAQ: BMRA Healthcare

Valuation

MetricValue
Price$1.61
Market Cap$4.98M
P/E Ratio-1.09
P/B Ratio1.82
P/S Ratio1.78
EPS (TTM)$0.00
52-Week High$4.60
52-Week Low$1.57
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-125.00%
ROA-83.33%
ROCE-125.00%
Gross Margin-100.00%
Operating Margin-100.00%
Net Margin-96.49%
Debt/Equity0.06
Current Ratio2.50

Annual Financials (USD)

Metric20212022202320242025
Revenue$7.0M$19.0M$5.0M$5.0M$5.0M
Operating Profit$-7.0M$-5.0M$-7.0M$-6.0M$-5.0M
Net Profit$-7.0M$-5.0M$-7.0M$-6.0M$-5.0M
EPS$-0.54$-0.36$-0.50$-0.36$-2.16
Op Margin-104.2%-24.0%-135.3%-117.6%-96.7%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$12.0M$11.0M$14.0M$9.0M$6.0M
Total Liabilities$3.0M$3.0M$3.0M$3.0M$2.0M
Cash$4.0M$6.0M$10.0M$4.0M$2.0M
Borrowings$2.0M$1.0M$1.0M$1.0M$0

Latest News

Biomerica Lands a $1.75 Million CDMO Master Services Agreement for IVD Diagnostic Development GlobeNewswire · May 28, 2026 Biomerica’s inFoods® IBS Data Accepted for Presentation at Digestive Disease Week 2026 GlobeNewswire · Apr 29, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$-5.0M$0$-5.0M$-5.0M$-4.0M
Investing Cash Flow$-1.0M$0$0$0$0
Financing Cash Flow$0$0$-1.0M$0$0
Net Cash Flow$-4.0M$2.0M$4.0M$-6.0M$-2.0M
Free Cash Flow$-6.0M$-1.0M$-6.0M$-5.0M$-4.0M

Valuation & Return Ratios

MetricValue
PEG Ratio—
EV / EBITDA—
FCF Yield-41.20%
Quick Ratio1.59
Interest Coverage—
Return 1Y-45.23%
Return 3Y-85.65%
Return 5Y-94.49%

Ownership

Insiders Held15.24%
Institutions Held3.62%
Institutions Float Held4.27%
Institutional HolderSharesReport Date
Geode Capital Management, LLC56,0422026-03-31
Blackrock Inc.18,6362026-03-31
Vanguard Capital Management LLC14,5142026-03-31
LPL Financial LLC10,8492026-03-31
Vanguard Fiduciary Trust Co6,6132026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
ALZN $1.35 +0.75% -0.11 $5.14M 0.00%
CELZ $0.79 -2.09% -1.47 $2.05M 0.00%
HSCS $2.18 +4.81% -0.70 $4.71M 0.00%
IINNInspira Technologies OXY B.H.N. Ltd. $1.26 -5.97% -2.80 $30.34M 0.00%
LFWD $7.00 -1.41% -0.39 $11.28M 0.00%

About BMRA

BMRA is led by CEO Zackary S. Irani, employs 64 people, headquartered in US, publicly traded since 1984.

BMRA stock trades at $1.61 with a market capitalization of $4.98M. The stock is valued at a price-to-earnings (P/E) ratio of -1.09, price-to-book of 1.82, price-to-sales of 1.78. Over the past 52 weeks the stock has ranged between $1.57 and $4.60, and currently trades 65.0% below its 52-week high.

On profitability, BMRA generates a return on equity (ROE) of -125.00%, return on capital employed of -125.00%, an operating margin of -100.00%, a net profit margin of -96.49%.

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides